nd enable formulation and analytical development on toxic substances. Through the use of these high containment isolators, our scientists create and maintain a controlled sterile envelope that enables us to safely process potent drug classes including cytotoxic antibody drug conjugates, cytotoxins, steroids, hormones and acutely toxic substances. Coldstream's scope of services ranges from proof-of-concept through to commercial manufacturing.
About Goodwin Biotechnology, Inc.
Goodwin Biotechnology is a world-class CMO that offers fully integrated, development and cGMP contract manufacturing of monoclonal antibodies, recombinant proteins, vaccines and Antibody Drug Conjugates (ADCs). By working with GBI, our clients can enhance the value of their product candidates with clear development and manufacturing strategies as well as a road map to meet the highest quality product requirements from the milligram and gram range to kilogram quantities as the product candidates move along the clinical approval pathway in a cost-effective, timely and cGMP compliant manner to enhance patients' lives. With over 20 years of experience as an independent contract manufacturer, GBI has worked as a strategic partner with companies of all sizes from small university spin-offs to major research institutes, government agencies and large, established and multinational biopharmaceutical companies.
For more information on antibody drug conjugation and other bioconjugation projects, please contact Goodwin Biotechnology:
Business Development Manager
For more information on high containment, as well as lyophilization and Fill & Finish capabilities, please contact Coldstream Laboratories:
Christopher Verbicky , PhD, MBA
Director Business Deve
Page: 1 2 3 4 Related biology technology :1
|SOURCE Goodwin Biotechnology, Inc.|
Copyright©2012 PR Newswire.
All rights reserved
. Lixte Biotechnology Announces Initiation Of A Phase I Trial Of Its Lead Anti-Cancer Compound, LB-1002
. Cytos Biotechnology Ltd Reports First Quarter 2013 Financial Results and Recent Development3
. Plandai Biotechnology, Inc. Announces Shipment Of First Machinery To South African Production Facility4
. PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs5
. Choose New Jersey and Partners to Promote New Jersey As Global Life Science Hub at Worlds Largest Biotechnology Event6
. Plandai Biotechnology, Inc. Enters Into License Agreement With Phyto Nutricare To Develop Nutraceutical Products7
. Biotechnology Market (Biopharmacy, Bioservices, Bioagri, Bioindustrial) Is Expected to Reach USD 414.5 Billion Globally in 2017: Transparency Market Research8
. NanoSight, One of the UKs Fastest Growing Biotechnology Companies, Wins a 2013 Queens Award for Enterprise - Innovation9
. Global Biotechnology Industry Market Research Report Now Available from IBISWorld10
. Plandai Biotechnology, Inc. Updates Progress Of Preparing Products For Market11
. San Diego State University Hosts Open House for Life Science Immersion Biotechnology Program